Merck KGaA has acquired Terns Pharmaceuticals in a deal valued at $6.7 billion.
1 report, 1 independent
Updated Jun 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Merck KGaA has acquired Terns Pharmaceuticals in a deal valued at $6.7 billion.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Merck KGaA
German multinational science and technology company